Boston Scientific Enters $2 Billion Accelerated Share Repurchase Agreement

Boston Scientific Corporation has announced a $2 billion accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank as part of a previously authorized $5 billion share buyback program. The ASR will initially provide 80% of the repurchase price in common stock, with a final number of shares to be determined by the stock’s average price during the ASR period. The total expected net impact to adjusted earnings per share is $0.02 for the full year 2026, with $3 billion remaining under the buyback authorization after this purchase.